For innovation to be successful it must be developed in collaboration with those set to use or benefit from it.

Involvement and co-production with people, public, carers, and communities is a growing and thriving agenda across the AHSN Network, and is even more important than it has ever been, given the experiences of the COVID-19 pandemic.

With this in mind, during 2020/2021 the Network reviewed activity across AHSNs to support a more strategic approach to involvement and co-production of innovation and developed its co-production strategy.

Read more about our approach to co-production and patient and public involvement.

View the AHSN Network Involvement Strategy.

  • 2025 NHS Innovation Accelerator Fellows  

    The NHS Innovation Accelerator (NIA) has revealed its 2025 cohort of Fellows. As the NIA celebrates a decade of helping to drive innovation in the NHS, this year’s cohort aligns with the Government’s three priorities: supporting the transition from analogue to digital, sickness to prevention and hospital to home.  The 28 new Fellows will benefit [...]

  • Launch of new “game changing” guide to tackle overprescribing and support Government’s shifts to prevention and community

    A new guide aimed at helping primary care organisations and integrated care boards understand and address problematic polypharmacy has been launched by the Health Innovation Network as part of its national Polypharmacy Programme. Developed in response to a clear need identified by primary care and prescribing colleagues, this essential resource provides practical, evidence-based strategies to [...]

  • Delivering the national cancer plan through innovation

    Across England, innovation is improving cancer services and patient outcomes. Last week the government launched an open call for evidence to inform the National Cancer Plan.  Innovation has a critical role to play in supporting the delivery of any National Cancer Plan, and delivering on the government’s three shifts. In order to realise the significant [...]